Sun Pharma

Sun Pharma recalls more than 10,000 bottles of generic anti-depression drug in US

Read more

Sun Pharma plans to launch oral lipid-lowering drug Brillo in India

Read more

Sun Pharma announces US FDA approval for generic Mesalamine Extended Release capsules

Read more

Sun Pharma gets Form 483 from US FDA for regulatory violations at Halol plant

Read more

Aurobindo and Sun Pharma recall products in US market

Read more

Sun Pharma to introduce its version of Vortioxetine in India

Read more

Sun Pharma to acquire 11.28 per cent stake in Zenotech from Daiichi Sankyo

Read more

Aurobindo and Sun Pharma recall products from US

Read more

Sun Pharma launches Cequa, maiden dry eye treatment with nanomicellar technology in Canada

Read more

Sun Pharma honours IIT Kanpur’s professor with Science Foundation Research Award-2021

Read more